Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

New glycogen phosphorylase inhibitors discovered by Aventis researchers

Jan. 16, 2003

Potential use of AMG-073 in dialysis patients with secondary hyperparathyroidism

Jan. 15, 2003

Efficacy of teriparatide unaffected by age, BMD or number of fractures

Jan. 15, 2003

Carbazole-based NPY Y5 modulators jointly reported by Boehringer Ingelheim and Novo Nordisk

Jan. 15, 2003

Takeda and Beth Israel Deaconess collaborate on metabolic diseases

Jan. 15, 2003

Wyeth claims new oxytocin antagonists with utility in preterm labor

Jan. 15, 2003

Wyeth researchers identify novel series of estrogenic compounds

Jan. 15, 2003

Chiron partners with GlaxoSmithKline for obesity program

Jan. 14, 2003

Sumitomo patents series of antidiabetic piperazines

Jan. 14, 2003

Japanese approval sought for Kissei's mitiglinide

Jan. 13, 2003

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 26, 2026.
Have brain-computer interfaces finally arrived?
BioWorld
More and more individuals now have chronically implanted brain-computer interface (BCI) systems in their heads. Devices that can record and stimulate neural...
News in brief
BioWorld Asia
BioWorld Asia briefs for June 23, 2026
Brain-computer interfaces are here but long road ahead
BioWorld
The field of BCI is continually evolving; as such, companies are increasingly highlighting the potential of their technologies to transform care. For advanced...
2026 marks critical turning point for BCI technology
BioWorld
Decades of research are helping unravel the “black box” of the brain. The second article in BioWorld’s series on the Brain-Computer Interface (BCI) field looks at...